Entering text into the input field will update the search result below

Cannabis Stocks Trading Mixed Despite News Of Tilray Deal

Sep. 02, 2019 6:01 AM ET
Please Note: Blog posts are not selected, edited or screened by Seeking Alpha editors.


  • Shares in Canada's major cannabis producers are trading mixed this Friday.

Tilray (TLRY) appears to be the worst affected after Thursday's announcement of a CAD 110 million deal to buy head-shop chain Four20, which owns and operates six recreational cannabis stores in Alberta. It is hoped that the acquisition, which will see Tilray buy up all of Four20's issued and outstanding shares, will help the cannabis producer expand its presence within Canada. Tilray will pay CAD 70 million for the shares when the deal eventually goes through at the end of Q1 2020, followed by an additional CAD 40 million "subject to the achievement of certain milestones" by Four20.Prior to this acquisition, Tilray completed another deal with Authentic Brands Group to supply this latter with CBD for use in products for sale in several major retail chains across the US and Canada.Despite the positive response to reports of a new deal, the company shares continue to fall and could even drop to the $5.00 mark over the short to medium term. Meanwhile, we could see Canopy Growth (CGC) slide to around $24.00 per unit share, with Cronos Group (CRON) and Aphria (APHA) rising to $11.00 and $7.00 respectively.

Seeking Alpha's Disclosure: Past performance is no guarantee of future results. No recommendation or advice is being given as to whether any investment is suitable for a particular investor. Any views or opinions expressed above may not reflect those of Seeking Alpha as a whole. Seeking Alpha is not a licensed securities dealer, broker or US investment adviser or investment bank. Our analysts are third party authors that include both professional investors and individual investors who may not be licensed or certified by any institute or regulatory body.

Recommended For You

To ensure this doesn’t happen in the future, please enable Javascript and cookies in your browser.
Is this happening to you frequently? Please report it on our feedback forum.
If you have an ad-blocker enabled you may be blocked from proceeding. Please disable your ad-blocker and refresh.